Aurobindo Pharma receives US FDA approval for allergic conjunctivitis solution
The approved product has an estimated market size of $235 million
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ANDA
Aurobindo Pharma receives USFDA approval for methylprednisolone sodium succinate injection
The approved product has an estimated market size of $102 million for the twelve months ending October 2015 according to IMS…
Aurobindo Pharma receives US FDA approval for tramadol hydrochloride extended-release tabs
Tramadol hydrochloride tabs are used in the treatment of moderate-to-severe pain in adults
Aurobindo Pharma has received final…
Jubilant Life Sciences gets US FDA nod
The drug is indicated for the acute treatment of migraine in adults and paediatric patients Jubilant Life Sciences has received…
Jubilant Life Sciences gets US FDA nod for anti-migraine tablets
The company's drug is a generic version of AstraZeneca's Zomig-ZMT tablets, which is used for acute treatment of migraine…
Aurobindo Pharma receives US FDA approval for Telmisartan tabs
Telmisartan tablets are indicated in the treatment of essential hypertension
Natco Pharma plans five new products for US market
The Rs 850-crore company expects to see organic growth of 15-20 per cent Natco Pharma is preparing to launch about four to five…
Wockhardt’s consolidated revenue for Q1FY16 grows by 15 per cent at Rs1141 crore
EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial year 2016. The…
Ajanta Pharma gets approvals for three ANDAs
Montelukast tablets are indicated for the treatment of prophylaxis and chronic treatment of asthma and to relieve symptoms of…
Jubilant Life Sciences receives ANDA approval for Levofloxacin tabs
It is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin…